Non-insulin injectables for T2D

Listen to the episode

Description

In this episode:

  • GLP1 agonists are a very important management option – GPs who have not yet used this class of medications should learn more and start
  • They are potent in lowering blood glucose levels, weight, is given once a week and have non glycaemic cardiovascular benefits
  • There are few contraindications and can be used in patients with very low eGFR
  • GLP1 agonists can be used as second line after metformin, third line and some can also be used with insulin

 

Host: Dr David Lim, GP and Medical Educator

Total time: 38 mins

Guest: A/Prof Neale Cohen, Endocrinologist

 

Last Updated: 16 Jul, 2021

Further your CPD learning

Based on this educational activity, complete these learning modules to gain additional CPD.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone

Prof Andrew Sindone

Heart Failure – Demystifying Pharmacological Management for GPs

Dr Rupert Hinds

Dr Rupert Hinds

Iron Deficiency in Children & Young People

Speaker TBA

Speaker TBA

Heart Failure – Assessment and Monitoring in Primary Care

Prof Dave Singh

Prof Dave Singh

COPD Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Neale Cohen

expert

A/Prof Neale Cohen

Endocrinologist; Director of Clinical Diabetes, the Baker Heart and Diabetes Institute, Melbourne

Recent articles

Share this

You have completed the Educational Activities component of this resource. 

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this resource in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.